ARQT Wutah bathi saben saham ing taun iki Arcutis Corp

Simbol resmi perusahaan arcutis.com (ARQT)

Arcutis Biotherapeutics (ARQT) leverages significant pricing power by adapting potent biologics into safe topical treatments. A comparison of annual EPS growth on the GURU.Markets chart shows that 311.30 is the current metric value. Scaling Zoryve sales creates operational leverage, reducing unit costs. The increasing number of prescriptions and the expansion of US insurance coverage serve as the primary growth catalysts.

Wutah bathi saben saham ing taun lumaku Arcutis (ARQT): kanggo periode 04.07.2022 - 17.11.2026

Rincian metrik komprehensif lan analitis arcutis.com (ARQT)

- kuotasi saiki lan rata-rata prakiraan nilai:
Ringkesan analisis perusahaan:Arcutis Biotherapeutics Inc - ARQT
Barang utama Arcutis Biotherapeutics

Conservative capital demands profit transparency to assess long-term solvency and business sustainability. This indicator measures the annual change in earnings per share, allowing for the identification of the real profitability trend regardless of quarterly fluctuations. For Arcutis Biotherapeutics (ARQT), this annual percentage change in earnings per share is critical, as it reflects the effectiveness of drug commercialization against a backdrop of high marketing expenses.